Eight traumatic spinal cord injured (SCI) individuals are described. Four tetraplegic patients who were weaned from initial ventilator use despite severe restrictive pulmonary syndromes experienced multiple pulmonary complications, episodes of acute respiratory failure, and 3 of the 4 required long term ventilatory support within 2 years of initial weaning. Three other SCI individuals developed chronic late-onset ventilatory failure 17, 25, and 29 years postinjury. One other tetraplegic patient was mechanically ventilated for 8.2 years post injury despite complete recovery of autonomous ventilatory function years earlier. Of the 6 patients requiring long term ventilatory support, 4 were managed by noninvasive techniques of intermittent positive pressure ventilation (IPPV), one by negative pressure body ventilators, and one by tracheostomy IPPV. At least one and possibly as many as 5 patients were spared broncho scopy and/or pulmonary complications by using mechanical insufflation-exsuf flation (MI-E). We conclude that patients who are weaned despite having significant restrictive pulmonary syndromes are at risk for ventilatory decompen sation weeks to decades after weaning. Ongoing clinical assessment, evaluation of respiratory muscle function and, at times, nocturnal blood gas analyses are warranted in the follow up of traumatic SCI individuals.
Introduction
Inspiratory muscle weakness can lead to chronic alveolar hypoventilation (CAH). The risk of pulmonary morbidity and mor tality correlates with the extent of hyper capnia,I, 2 and, at least for individuals with restrictive pulmonary conditions, with dif ficulty in clearing airway secretions from inadequate peak cough expiratory flows (PCEFs) due to expiratory muscle weak ness.3 For neuromuscular patients awake hypercapnia generally develops when the vital capacity (VC) sitting decreases to 40% 4 to 55% 5 of predicted normal.
However, CAH is often first noted as hypercapnia during sleep. 6 When ventila tion becomes normal by the use of respirat ory muscle assistance including ventilatory support, blood gases improve, the risk of pulmonary complications decreases, and survival is prolonged,7-13 with the greatest benefit for patients without significant con comitant lung disease.
In the general population the VC plateaus at age 19 and then decreases at a rate of 1 % to 1.2% or about 30 ml per year. 14 The VCs of individuals with progressive neuro muscular conditions can plateau during childhood and then decrease rapidly.ls, 16 The VC also decreases during acute para lytic poliomyelitis. It recovers to varying degrees, plateaus, then decreases once again by as much as 1.7% 17 to 1.9% 18 per year. CAH develops and, although con sidered a relatively stable condition, post-poliomyelitis individuals may experi ence numerous pulmonary complications and late-onset ventilator dependence. 19 This is particularly true for individuals who used ventilators during acute poliomyelitis. In one study 71 individuals required late onset ventilatory assistance 3 to 59 years or a mean of 29 ± 12.1 years post poliomyel itis. 1 9
Ventilatory assistance is often initially required overnight and only gradually be comes necessary during daytime hours. In a recent study, neuromuscular patients re quired nocturnal ventilatory assistance when their supine VCs had decreased to about 30% of predicted normal. 7 Although supine VC measurements are useful they are not often performed.
For patients with traumatic tetraplegia who may or may not have required ventila tor use at the onset, the VC also plateaus at some time following injury and then de creases with age. The VCs in the sitting position of stable C4-C7 tetraplegics range from 42% (range = 28-63% ) 20 to 52 ± 11 % 2 1 of predicted normal. However, supine VCs which are usually greater than sitting VCs may be significantly less than sitting VCs when the patient is adept at supplementing inspiratory volumes by ac cessory muscle use. With the loss of pul monary volumes and function over time, we report for the first time that some SCI individuals are, in fact, subject to late-onset chronic ventilatory insufficiency. Likewise, patients may be inappropriately weaned from ventilator use during the initial injury recovery period or be maintained on vent ilatory support longer than needed. These points, too, have not been previously re ported. Basic patient data are provided in Table I .
Case studies:
Late-onset chronic ventilatory failure Case 1, a male tetraplegic, developed a mild S-shaped thoracolumbar curve and hyper somnolence due to CAH in 1969, 12 years postinjury. He was treated for 5 years with Ventilatory management for SCI patients 431 24-hour home oxygen therapy. However, his pC02 increased to 70 to 80 mmHg and the hypersomnolence worsened. His first hospital admission for respiratory failure was triggered by an upper respiratory tract infection (URI) in 1974. He was intubated, had a tracheostomy and received tracheos tomy IPPV for 3 weeks before weaning and tracheostomy site closure. Subsequent com plications were associated with episodes of bronchitis and/or pneumonia before begin ning definitive daily ventilatory aid (Table  Ib) . In 1983, he developed right ventricular failure and had three respiratory arrests during attempts to wean from IPPV via a nasotracheal tube following urological sur gery. He was converted to nocturnal chest shell ventilator aid which he used for 4 years. He then switched to a negative pressure wrap ventilator until 1989. From 1983 to 1989 he was hospitalised on nine occasions and intubated eight times. He had undergone bronchoscopic mucus removal on 13 occasions by this time. In 1989, with a VC of 450 ml sitting and 580 ml supine, arterial blood gases and continuous non invasive blood gas monitoring demonstrated the ineffectiveness of nocturnal wrap vent ilator use. Awake, unaided pC0 2 ranged from 55 mmHg to 95 mmHg and p0 2 from 40 mmHg to 50 mmHg on room air. The results of the nocturnal Sa0 2 monitoring are given in Table II . He was switched to nocturnal mouthpiece IPPV but refused to use a Bennett lip seal (Puritan-Bennett, Boulder, CO), which is recommended for overnight use,8 because of the inability to independently remove the retention straps to use a sip-and-puff operated telephone during the night. His blood gases were not significantly improved by using nocturnal mouthpiece IPPV without a lipseal. Since he retained fair plus strength of the right biceps a pulley system was devised which allowed him to use a lipseal and remove it independ ently (Fig 1) . Lipseal IPPV resulted in normalization of nocturnal Sa0 2 and alve olar ventilation with the latter monitored by end-tidal CO 2 measurements. Oximetry and occasionally capnography biofeedback demonstrated normalization of Sa0 2 and alveolar ventilation during daytime mouth piece IPPV. Mouthpiece IPPV also relieved gDaytime mouthpiece IPPV used during respiratory tract infections.
hMechanical insufflation-exsufflation was used on a daily basis to remove airway secretions and for periodic hyperinsufflation.
daytime fatigue and dyspnea. 22 . 2 3 His VC increased to 720 ml sitting and 760 ml supine within 4 months. His need of mouthpiece IPPV to maintain normal Sa0 2 decreased from 24 hours to, currently, 14 hours per day. He has had neither respiratory compli cations nor hospitalizations over the last 4 years and has relied on mechanical insuffla tion-exsufflation (MI-E) (The In-exsuf flator, J H Emerson Company, Cambridge, chial secretions, frequent awakening from sleep with tachycardia and the sensation of suffocating, orthopnea, and depression in 1978, 29 years following a T5 spinal injury at birth. She could generate only short, faintly spoken sentences. There was severe edema, right ventricular insufficiency, and moder ate scoliosis. Her VC was 730 ml sitting. Oxygen therapy did not relieve the symp toms. After one episode of pneumonia, and severe hypercapnia which resulted in two respiratory arrests, hospitalization, and iron lung use, she was placed on nocturnal lipseal IPPV.8 Supplemental oxygen was discon tinued. Her symptoms were completely relieved and daytime blood gases improved. She has had neither pulmonary complica tions nor hospital readmission over the past 15 years. Sleep oximetry on lipseal IPPV supine demonstrated a mean Sa0 2 of 97% . During URIs she requires mouthpiece IPPV 24 hours a day for adequate alveolar vent ilation and to improve her cough. Her VC has decreased to 690 ml sitting (21% of predicted normal) and 585 ml (16% of pre dicted) supine since 1978.
Case 3 is an out-of-state male tetraplegic physician who required ventilatory support for 3 weeks following injury in 1968, with no respiratory difficulties until 1985. From 1985 to September 1987 he was hospital ized, intubated, and weaned from ventilator use to continuous home oxygen therapy on three occasions. On the last occasion, just prior to intubation for an acute respirat ory arrest, his pC0 2 was noted to be 105 mmHg. With IPPV he awoke, was stabilized, then extubated and placed on nocturnal nasal IPPV in July 1987. This improved alveolar ventilation and daytime blood gases temporarily but he became severely hypercapnic when unaided. The use of daytime ventilatory aid was not arranged. Dyspnea increased and he be came uncomfortable with commercial nasal interfaces. Custom interfaces were not ob tained. There was also no use of effective assisted coughing. He was hospitalized for ventilatory insufficiency in August 1988, and hospitalized and intubated for several month periods in March 1989 and three times in 1990. In January of 1991 he arrested while in his hospital office, and he was intubated, resuscitated, and underwent tracheostomy which he continues to use 24 hours a day. He ceased all employment activities at that time. Laryngeal damage, presumably from intubation, has prevented effective verbal communication since January 1991. He has had multiple episodes of mucus plugging, pneumonia, acute res piratory insufficiency and intensive care admissions since January 1991.
Inappropriate ventilator weaning
Case 4 is a tetraplegic lady who was injured at age 12 years in 1970. She received tracheostomy IPPV for 6 weeks then was weaned and the tracheostomy site was alJowed to close. However, she was symp tomatic for hypoventilation with fatigue and sleep arousals with dyspnea and tachy cardia. She also developed pneumonia and ventilatory failure on three occasions during the first 2 years postinjury. At age 14 she was placed on nocturnal lip seal IPPV. She also used mouthpiece IPPV for daytime periods when fatigued and during URIs. Her VC plateaued at age 17 years at 760 ml sitting. She had no further complications nor hospitalizations from 1972 until at least 1985 when she was lost to follow up. By age 27 in 1985 her VC had decreased to 670 ml (18%) sitting and 700 ml (19%) supine.
Case 5, a 36 year old male tetraplegic patient, was injured in 1976. He was intub ated and had a tracheostomy for IPPV for 2 months, then weaned, and returned asymp tomatic to the community. In July 1977 an URI developed into pneumonia and res piratory failure. Weaning was not possible without dyspnea and hypercarnia. His symptoms were relieved by nocturnal chest shell ventilator use. After one year he switched to more effective nocturnal iron lung use. He has had four URIs but no respiratory complications nor hospital izations while using negative pressure aids. He currently has no ability to breathe autonomously when supine. He is also hypercapnic and dyspneic when sitting and using accessory muscles. The chronic care facility in which he resides, however, does not permit the use of positive pressure ventilators for daytime use.
Case 6 is a 29 year old male tetraplegic patient. He was intubated, used tracheos tomy IPPV for 5 months, then weaned and the tracheostomy site was closed despite a VC of 450 ml sitting and complaints of chronic fatigue. Four months later an URI developed into pneumonia. Ventilatory failure was treated by 24-hour mouthpiece IPPV. He was subsequently weaned to nocturnal lipseal IPPV. At yearly evalu ations from 1981 to 1986 his sitting VCs were 450 ml, 460 ml, 580 ml, 890 ml, 910 ml, and 960 ml, respectively. On April 20, 1988 he had a sitting VC of 1350 ml (37% of predicted) and supine VC of 800 ml (20% of predicted). Nocturnal oximetry during un aided sleep yielded a mean Sa0 2 of 96% with occasional severe desaturations associ ated with chest wall spasticity. Mouthpiece IPPV was discontinued without subsequent complications and his VC sitting increased to 2300 ml in June 1992.
Case 7 is a male tetraplegic patient with a 29 year history of two packs/day of cigarette use. He was weaned from ventilator use 2 months postinjury. The tracheostomy tube was capped and he was given supplemental oxygen. Three days after rehabilitation admission, with profuse secretions, he de veloped pneumonia, became ventilator dependent for 3 weeks, then was once again weaned to oxygen therapy. At this time his tracheostomy site was allowed to close but secretions remained profuse and purulent. Two episodes of respiratory failure neces sitated bronchoscopic removal of mucus plugs over the next 2 months. He was then referred to a rehabilitation ventilator unit. His VC was 900 ml, oxygen therapy was discontinued and Sa0 2 varied from 93% to 80% with end-tidal pC0 2 to greater than 50 mmHg. He was placed on mouthpiece IPPV with oximetry biofeedback and noc turnal nasal IPPV to normalize ventilation and E rovide deep breaths for assisted cough ing. 2 His maximum unassisted PCEFs were 1.21/s. He had frequent sudden oxyhemo globin de saturations below 80% which were corrected with the elimination of profuse secretions and mucus plugs by MI-E co ordinated with manually applied abdominal thrusts. Immediately following the initial use of MI-E his VC rose to 1200 ml. He required MI-E every 15 minutes during daytime hours for 2 days at which point secretions diminished, Sa0 2 remained over 94%, VC increased to 1600 ml and he discontinued IPPV. Hc was able to com plete his rehabilitation program without further incident.
Inappropriate continuation of ventilator use Case 8, a 24 year old male tetraplegic patient, used 24 hour/day tracheostomy IPPV for 6 months. At that point he Ventilatory management for SCI patients 435 developed a maximum of 1 hour of ventil ator-free time with a VC of 340 ml. Vent ilator-free time gradually increased and he was weaned to overnight IPPV over the next 4 months. He was discharged home and instructed to 'never stop using ventilatory support'. He suffered two lung collapses and pneumonia 3 years postinjury but had no other difficulties and underwent no further pulmonary function testing until presenting to us 8.2 years postinjury. At that time his VC was 2920 ml sitting and 3170 ml supine. Mean nocturnal Sa0 2 was 96% with a low of 91 %. IPPV was discontinued and the trach eostomy site closed. His VC increased to 4200 ml sitting and 3600 ml supine at 13 years postinjury.
Discussion
Four of the 6 tetraplegic patients who were ventilator weaned following acute injury developed the need for long term ventilator use. Two other patients developed late onset need for long term ventilator use without previous need in the postinjury period. As with post-poliomyelitis patients, ventilator use at disease onset and the presence of back deformity both appear to be risk factors for late-onset chronic venti latory insufficiency and justify close surveil lance of inspiratory and expiratory muscle function. The former can be conveniently monitored by VC and/or maximum inspir atory pressure measurements. Nocturnal Sa0 2 monitoring should be performed whenever there are symptoms suggestive of CAH or sleep disordered breathing, day time blood gases are abnormal, or if the supine VC decreases below 30% to 40% of predicted normal. Practical expiratory muscle function can be conveniently evalu ated by measuring PCEFs with a simple peak flow meter. 22 If untreated CAH can lead to pulmonary complications and acute respiratory failure. Acute failure is often triggered by an inter current URI during which increased expir atory muscle weakness. profuse airway secretions, and impaired secretion clearance alter pulmonary ventilation/perfusion and increase the work of breathing. Although none of these patients were obese nor had complicating medical conditions and only 2 had back deformity, all except cases 7 and 8 required ongoing ventilatory support and the need for 24-hour ventilatory aid during URIs.
Cases 1, 2 and 3 demonstrated that late-onset ventilatory insufficiency could develop insidiously in SCI patients. These patients had complications and repeated hospitalizations despite oxygen therapy but were successfully treated by 8 to 24 hour noninvasive IPPV. Once adequate alveolar ventilation was achieved the risk of further respiratory complications was greatly dimin ished. Oximetry biofeedback, manually as sisted coughing and MI-E were also vital during intercurrent URIs and facilitated management in the home. The successful use of these techniques has also been described for other patient popula tions.8.1 9 .23,25
In addition, case 1 demonstrated that nocturnal ventilatory aid alone may not be adequate indefinitely, and that the use of negative pressure body ventilators may be associated with severe, presumably ob structive sleep apneas. 26 The use of mouth piece IPPV during sleep without a lipseal may not provide normal alveolar ventila tion. The apparent improvement in central ventilatory drive achieved by correcting alveolar ventilation during daytime hours may also improve the effectiveness of noc turnal mouthpiece IPPV.8 Similar observa tions have been made for patients using nocturnal nasal IPPV. 7 Case 1 also demons trated that with effective ventilatory assist ance and relief of accessory muscle use and fatigue, VC and ventilator-free time can at least temporarily increase despite eventual diminution of VC with aging. Further, this patient's severely diminished unassisted PCEFs caused a high risk of pulmonary complications during URIs and following general anesthesia. PCEFs were not signific antly increased by manually assisted cough ing because of poor pulmonary compliance but were adequate with MI-E.
Both cases 1 and 2 demonstrated that right ventricular insufficiency could be re versed by using noninvasive ventilatory assistance. Case 2 also demonstrated the The latter is even more effective when used in conjunction with abdominal thrusts dur ing the exsufflation phase. Its use averted further episodes of respiratory failure and bronchoscopy in case 7. Since respiratory muscle dysfunction is increased both during URIs30 and by hypercapnia,3 2 .33 MI-E was vital in managing the intercurrent URIs for the 4 patients in this study with access to it. Its capacity to eliminate the need for bronchoscopy in ventilator supported indi viduals has been previously established. [34] [35] [36] [37] [38] Case 8 demonstrated a need for continued evaluation following acute rehabilitation. The need for nocturnal ventilatory assist ance is uncommon for adults with greater than 1500 ml or 30% -40% of predicted supine VC unless there are complicating medical conditions, obesity, kyphoscoliosis, malnutrition, or sleep disordered breath ing.1 9
References
Ventilatory management for SCI patients 437
In conclusion, these patients demons trated the late-onset necessity for ventil atory assistance and the effectiveness of regimens of noninvasive IPPV and airway secretion elimination as alternatives to tracheostomy. Any SCI individual with a history of repeated pneumonia, atelectasis, recent ventilatory support requirement, a VC supine less than 30% to 40% of pre dicted normal, nocturnal hypercapnia and mean Sa0 2 less than 95%, possibly com plicating sleep disordered breathing, and possibly subtle symptoms of CAH is a candidate for nocturnal noninvasive IPPV and the use of expiratory muscle aids as needed.22•23 Supplemental oxygen therapy does not decrease the risk of pulmonary complications and is unnecessary for pa tients without significant intrinsic lung disease who receive adequate ventilatory assistance. It can also hinder the use of oximetry in gauging alveolar ventilation, the effectiveness of noninvasive aids, and the presence and severity of mucus plugging. Patients unable to generate PCEFs of greater than 6l/s by manually assisted coughing may benefit from MI-E during periods of airway hypersecretion. Ventilator dependent tetraplegics with adequate bul bar muscle function can also be switched from tracheostomy IPPV to noninvasive IPPV despite having little or no measurable VC or ventilator-free time. The issues concerning this approach have been de scribed. 22 . 2 9 , 3 9
